Endoscopy 2004; 36(12): 1074-1079
DOI: 10.1055/s-2004-826045
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Evidence of Small-Bowel Involvement in Hereditary Hemorrhagic Telangiectasia: a Capsule-Endoscopic Study

M.  Ingrosso1 , C.  Sabbà2 , A.  Pisani1 , M.  Principi1 , M.  Gallitelli2 , A.  Cirulli2 , A.  Francavilla1
  • 1Dept. of Organ Transplantation, Gastroenterology Section, University of Bari, Bari, Italy
  • 2Dept. of Internal Medicine and Public Health/University Interdepartmental HHT Center, University of Bari, Bari, Italy
Weitere Informationen

Publikationsverlauf

Submitted 23 January 2004

Accepted after Revision 11 August 2004

Publikationsdatum:
01. Dezember 2004 (online)

Preview

Background and Study Aims: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant vascular disorder leading to telangiectases and arteriovenous malformations of the skin, mucosa, and viscera. Telangiectases in the upper gastrointestinal tract are known, but data regarding possible small-bowel involvement are scarce due to the technical difficulty of exploring the entire gastrointestinal tract. The aim of the present study was to use capsule endoscopy (CE) to determine the prevalence of small-bowel telangiectases in HHT patients.
Patients and Methods: From December 2001 to September 2002, 20 consecutive adult HHT patients at an interdepartmental HHT center were prospectively evaluated. All patients underwent esophagogastroduodenoscopy (EGD) followed by CE within 24 h. The telangiectases were scored according to commonly accepted criteria by two endoscopists and two observers of the video-capsule images, who were blinded to each other’s findings.

Results: EGD revealed gastric telangiectases in 15 of the 20 patients (75 %), while CE demonstrated small-bowel involvement in 10 of 18 patients (56 %; images were not recorded for two patients due to battery failure). No preferential site for telangiectasia was found between the jejunum and the terminal ileum. All patients who were positive on CE were also found to have gastric involvement at EGD. Patients with small-bowel telangiectases were significantly older than those without (62.5 years vs. 45 years; P < 0.02).
Conclusions: This study established a 56 % prevalence of small-bowel telangiectases in patients with HHT. This new endoscopic technique will probably change the etiological diagnosis of occult bleeding in HHT patients (which is too often attributed only to epistaxis) and may also be able to alter treatment strategies in HHT patients with gastrointestinal bleeding.

References

C. Sabbà, M. D.

Dept. of Internal Medicine · University of Bari Hospital

Piazza Giulio Cesare 11 · Bari · Italy 70124

Fax: +39-080-5478708

eMail: c.sabba@dimimp.uniba.it